MAXHEALTH1,033.10

Max Healthcare Institute Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISMEDANTADRREDDYCIPLASUNPHARMADIVISLABTORNTPHARMMcap ₹1.01L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity12.5011.4713.4213.42
Return on Assets8.817.078.378.37
Return on Capital Employed11.6011.1111.9411.94
Return on Invested Capital11.079.7111.4011.58
Margins
EBITDA Margin27.6026.3026.7926.61
Operating Margin23.0721.1921.4521.45
Incremental Operating Margin14.9322.82
Pretax Margin25.2620.0120.0119.64
Net Income Margin19.5615.3117.2316.73
Net Income to Common Margin19.44
FCF Margin6.357.031.781.78
Additional
Effective Tax Rate22.5423.5013.9214.84
Dvd Payout Ratio9.1713.5310.10
Sustainable Growth Rate11.359.9212.0713.42
Incremental Operating Margin %14.9322.8214.18
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.